ClearSign Technologies (CLIR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 annual meeting will be held virtually on July 25, 2025, with voting on director elections, auditor appointment, and executive compensation.
Stockholders of record as of May 29, 2025, are eligible to vote; 52,422,532 shares outstanding.
The Board recommends voting FOR all proposals and urges use of the WHITE proxy card.
Proxy materials are available online, reducing environmental impact and costs.
Voting matters and shareholder proposals
Proposals include electing six directors, approving BPM CPA LLP as auditor, and a say-on-pay vote for executive compensation.
A contested nomination by Jeffrey Feinglas was deemed invalid; any votes for his nominees will not be counted unless a court rules otherwise.
Board recommends voting FOR Schrecker, de Lacy, Silva, Deller, DiGiandomenico, and Basenese.
Advance notice requirements for 2026 proposals are detailed, with deadlines and compliance procedures.
Board of directors and corporate governance
Board will reduce from seven to six members after the meeting due to a director not standing for re-election.
Recent cooperation agreements led to the appointment of DiGiandomenico and Basenese.
All directors except Deller and DiGiandomenico are independent per Nasdaq rules.
Board has Audit, Compensation, and Governance Committees, all comprised of independent directors.
Lead independent director role is held by Schrecker, with defined responsibilities.
Latest events from ClearSign Technologies
- Reverse stock split and adjournment proposals both passed with strong shareholder support.CLIR
EGM 202626 Feb 2026 - Record revenue, robust pipeline, and expanding partnerships drive strong growth outlook.CLIR
Status update24 Feb 2026 - Stockholders to vote on a reverse stock split to maintain Nasdaq listing and enhance flexibility.CLIR
Proxy Filing2 Feb 2026 - Shareholders will vote on a reverse stock split to help maintain Nasdaq listing and board flexibility.CLIR
Proxy Filing23 Jan 2026 - Q2 2024 saw revenue fall, net loss rise, and cash surge on equity raises amid major new orders.CLIR
Q2 202423 Jan 2026 - Near-zero NOx burners gain traction, boosting sales and nearing break-even in key U.S. markets.CLIR
17th Annual LD Micro Main Event Conference18 Jan 2026 - Record revenue, margin gains, and strong liquidity highlight accelerating business momentum.CLIR
Q3 202413 Jan 2026 - Record revenue, product launches, and partnerships drive growth amid margin pressure.CLIR
Q4 202426 Dec 2025 - Shelf registration allows up to $50M in offerings, with $10.39M ATM sales via H.C. Wainwright & Co.CLIR
Registration Filing16 Dec 2025